Gujarat themis biosyn trend analysis

23 thg 4, 2021

As we can see in the chart the stock has given a breakout after a reasonably good fall over a period of time, this can be a good buy because this company makes pharmaceutical products namely rifampicin which is useful in fighting bacterial infections which might prove as the benefit due to the pandemic which is going on. Further the company has pretty impressive fundamentals with a whooping ROCE of 83% (there is a lot more to its fundamentals which you can check on internet), and at last its a debt-free company.